HAL (France)open access
Comparative safety of enoxaparin versus other low-molecular-weight heparins in cancer-associated venous thromboembolism: a real-world cohort study from RIETE
Nonsteroid antiinflammatory agent, Low-molecular-weight heparins, Corticosteroid, Venous thromboembolism, Mortality, Dalteparin, 0, Recurrences
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1120428
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.